Instil Bio News

Jefferies Investment Bank: Downgraded the Instil Bio (TIL.US) rating from buy to hold, and adjusted the target price from $5.00 to $11.00.

Zhitong FinanceApr 12 21:30

Instil Bio Analyst Ratings

BenzingaApr 12 21:22

Jefferies Downgrades Instil Bio to Hold, Raises Price Target to $11

BenzingaApr 12 21:24

Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Instil Bio (TIL) and Regeneron (REGN)

TipRanksApr 12 17:20

Instil Bio Analyst Ratings

BenzingaMar 25 18:06

HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $18 Price Target

BenzingaMar 25 18:08

Analysts' Top Healthcare Picks: Instil Bio (TIL), Evolus (EOLS)

TipRanksJan 23 04:30

Instil Bio Analyst Ratings

BenzingaJan 20 03:12

Baird Maintains Outperform on Instil Bio, Lowers Price Target to $54

BenzingaJan 18 03:34

Instil Bio Analyst Ratings

BenzingaJan 18 03:32

HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $2 Price Target

BenzingaNov 14, 2023 19:27

Instil Bio Analyst Ratings

BenzingaNov 14, 2023 19:26

Truist Financial Remains a Hold on Instil Bio (TIL)

TipRanksSep 7, 2023 10:25

HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $2 Price Target

BenzingaAug 17, 2023 18:33

Instil Bio Analyst Ratings

BenzingaAug 17, 2023 18:33

Analysts Are Bullish on Top Healthcare Stocks: Relay Therapeutics (RLAY), Instil Bio (TIL)

TipRanksAug 17, 2023 18:30

Instil Bio (TIL) Gets a Buy From H.C. Wainwright

TipRanksJun 29, 2023 18:15

HC Wainwright & Co. Initiates Coverage On Instil Bio With Buy Rating, Announces Price Target of $2

BenzingaJun 29, 2023 18:10

Analysts Offer Insights on Healthcare Companies: Instil Bio (TIL) and Regulus (RGLS)

TipRanksMay 15, 2023 20:20

Truist Securities Reinstates Hold on Instil Bio, Maintains $6 Price Target

BenzingaApr 5, 2023 20:55